2026 26110_15th Annual MCW Pancreatic Cancer Symposium Evaluation

1 Start 2 Complete

Overall Symposium

Please rate the 15th Annual Pancreatic Cancer Symposium on the following:

	Strongly Agree	Agree	Neither Agree nor Disagree	Disagree	Strongly Disagree
Overall, the symposium met my expectations.	Overall, the symposium met my expectations. - Strongly Agree	Overall, the symposium met my expectations. - Agree	Overall, the symposium met my expectations. - Neither Agree nor Disagree	Overall, the symposium met my expectations. - Disagree	Overall, the symposium met my expectations. - Strongly Disagree
The content of the symposium met my expectations.	The content of the symposium met my expectations. - Strongly Agree	The content of the symposium met my expectations. - Agree	The content of the symposium met my expectations. - Neither Agree nor Disagree	The content of the symposium met my expectations. - Disagree	The content of the symposium met my expectations. - Strongly Disagree
The format was conducive to the meeting.	The format was conducive to the meeting. - Strongly Agree	The format was conducive to the meeting. - Agree	The format was conducive to the meeting. - Neither Agree nor Disagree	The format was conducive to the meeting. - Disagree	The format was conducive to the meeting. - Strongly Disagree
The location of the meeting was convenient.	The location of the meeting was convenient. - Strongly Agree	The location of the meeting was convenient. - Agree	The location of the meeting was convenient. - Neither Agree nor Disagree	The location of the meeting was convenient. - Disagree	The location of the meeting was convenient. - Strongly Disagree

Sessions

Please evaluate the content of each of the following sessions/discussions

	Extremely Satisfied	Satisfied	Neither Satisfied nor Dissatisfied	Dissatisfied	Did Not Attend
"Welcome" - Douglas B. Evans, MD	"Welcome" - Douglas B. Evans, MD - Extremely Satisfied	"Welcome" - Douglas B. Evans, MD - Satisfied	"Welcome" - Douglas B. Evans, MD - Neither Satisfied nor Dissatisfied	"Welcome" - Douglas B. Evans, MD - Dissatisfied	"Welcome" - Douglas B. Evans, MD - Did Not Attend
"GI ASCO 2026 Updates" - Mandana Kamgar, MD, MPH	"GI ASCO 2026 Updates" - Mandana Kamgar, MD, MPH - Extremely Satisfied	"GI ASCO 2026 Updates" - Mandana Kamgar, MD, MPH - Satisfied	"GI ASCO 2026 Updates" - Mandana Kamgar, MD, MPH - Neither Satisfied nor Dissatisfied	"GI ASCO 2026 Updates" - Mandana Kamgar, MD, MPH - Dissatisfied	"GI ASCO 2026 Updates" - Mandana Kamgar, MD, MPH - Did Not Attend
"Surmounting Barriers: Enhancing Anti-tumor Immunity in Pancreatic Cancer" - Jeremy B. Jacox, MD, PhD	"Surmounting Barriers: Enhancing Anti-tumor Immunity in Pancreatic Cancer" - Jeremy B. Jacox, MD, PhD - Extremely Satisfied	"Surmounting Barriers: Enhancing Anti-tumor Immunity in Pancreatic Cancer" - Jeremy B. Jacox, MD, PhD - Satisfied	"Surmounting Barriers: Enhancing Anti-tumor Immunity in Pancreatic Cancer" - Jeremy B. Jacox, MD, PhD - Neither Satisfied nor Dissatisfied	"Surmounting Barriers: Enhancing Anti-tumor Immunity in Pancreatic Cancer" - Jeremy B. Jacox, MD, PhD - Dissatisfied	"Surmounting Barriers: Enhancing Anti-tumor Immunity in Pancreatic Cancer" - Jeremy B. Jacox, MD, PhD - Did Not Attend
"MEKi in G12R" - Tommy McFall, PhD	"MEKi in G12R" - Tommy McFall, PhD - Extremely Satisfied	"MEKi in G12R" - Tommy McFall, PhD - Satisfied	"MEKi in G12R" - Tommy McFall, PhD - Neither Satisfied nor Dissatisfied	"MEKi in G12R" - Tommy McFall, PhD - Dissatisfied	"MEKi in G12R" - Tommy McFall, PhD - Did Not Attend
"Redefining the Role of Radiation Therapy in Pancreatic Adenocarcinoma, Local Control is Just the Beginning" - William Hall, MD	"Redefining the Role of Radiation Therapy in Pancreatic Adenocarcinoma, Local Control is Just the Beginning" - William Hall, MD - Extremely Satisfied	"Redefining the Role of Radiation Therapy in Pancreatic Adenocarcinoma, Local Control is Just the Beginning" - William Hall, MD - Satisfied	"Redefining the Role of Radiation Therapy in Pancreatic Adenocarcinoma, Local Control is Just the Beginning" - William Hall, MD - Neither Satisfied nor Dissatisfied	"Redefining the Role of Radiation Therapy in Pancreatic Adenocarcinoma, Local Control is Just the Beginning" - William Hall, MD - Dissatisfied	"Redefining the Role of Radiation Therapy in Pancreatic Adenocarcinoma, Local Control is Just the Beginning" - William Hall, MD - Did Not Attend
"Mechanisms of Cancer-Nerve Crosstalk in Pancreatic Cancer" - William Hwang, MD, PhD	"Mechanisms of Cancer-Nerve Crosstalk in Pancreatic Cancer" - William Hwang, MD, PhD - Extremely Satisfied	"Mechanisms of Cancer-Nerve Crosstalk in Pancreatic Cancer" - William Hwang, MD, PhD - Satisfied	"Mechanisms of Cancer-Nerve Crosstalk in Pancreatic Cancer" - William Hwang, MD, PhD - Neither Satisfied nor Dissatisfied	"Mechanisms of Cancer-Nerve Crosstalk in Pancreatic Cancer" - William Hwang, MD, PhD - Dissatisfied	"Mechanisms of Cancer-Nerve Crosstalk in Pancreatic Cancer" - William Hwang, MD, PhD - Did Not Attend
"Intercepting Metastasis by Targeting the Pro-tumor Niche" - Nikki Lytle, PhD	"Intercepting Metastasis by Targeting the Pro-tumor Niche" - Nikki Lytle, PhD - Extremely Satisfied	"Intercepting Metastasis by Targeting the Pro-tumor Niche" - Nikki Lytle, PhD - Satisfied	"Intercepting Metastasis by Targeting the Pro-tumor Niche" - Nikki Lytle, PhD - Neither Satisfied nor Dissatisfied	"Intercepting Metastasis by Targeting the Pro-tumor Niche" - Nikki Lytle, PhD - Dissatisfied	"Intercepting Metastasis by Targeting the Pro-tumor Niche" - Nikki Lytle, PhD - Did Not Attend
"Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer" - Leonid Cherkassky, MD	"Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer" - Leonid Cherkassky, MD - Extremely Satisfied	"Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer" - Leonid Cherkassky, MD - Satisfied	"Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer" - Leonid Cherkassky, MD - Neither Satisfied nor Dissatisfied	"Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer" - Leonid Cherkassky, MD - Dissatisfied	"Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer" - Leonid Cherkassky, MD - Did Not Attend
"AI in Diagnostic Imaging" - Parag Tolat, MD	"AI in Diagnostic Imaging" - Parag Tolat, MD - Extremely Satisfied	"AI in Diagnostic Imaging" - Parag Tolat, MD - Satisfied	"AI in Diagnostic Imaging" - Parag Tolat, MD - Neither Satisfied nor Dissatisfied	"AI in Diagnostic Imaging" - Parag Tolat, MD - Dissatisfied	"AI in Diagnostic Imaging" - Parag Tolat, MD - Did Not Attend
"The Future of CAR T Cell Therapy in Solid Tumors" - Nirav Shah, MD	"The Future of CAR T Cell Therapy in Solid Tumors" - Nirav Shah, MD - Extremely Satisfied	"The Future of CAR T Cell Therapy in Solid Tumors" - Nirav Shah, MD - Satisfied	"The Future of CAR T Cell Therapy in Solid Tumors" - Nirav Shah, MD - Neither Satisfied nor Dissatisfied	"The Future of CAR T Cell Therapy in Solid Tumors" - Nirav Shah, MD - Dissatisfied	"The Future of CAR T Cell Therapy in Solid Tumors" - Nirav Shah, MD - Did Not Attend
"Case Discussion" - Douglas Evans, MD & Kathleen Christians, MD	"Case Discussion" - Douglas Evans, MD & Kathleen Christians, MD - Extremely Satisfied	"Case Discussion" - Douglas Evans, MD & Kathleen Christians, MD - Satisfied	"Case Discussion" - Douglas Evans, MD & Kathleen Christians, MD - Neither Satisfied nor Dissatisfied	"Case Discussion" - Douglas Evans, MD & Kathleen Christians, MD - Dissatisfied	"Case Discussion" - Douglas Evans, MD & Kathleen Christians, MD - Did Not Attend
"Concluding Remarks" - Douglas Evans, MD	"Concluding Remarks" - Douglas Evans, MD - Extremely Satisfied	"Concluding Remarks" - Douglas Evans, MD - Satisfied	"Concluding Remarks" - Douglas Evans, MD - Neither Satisfied nor Dissatisfied	"Concluding Remarks" - Douglas Evans, MD - Dissatisfied	"Concluding Remarks" - Douglas Evans, MD - Did Not Attend

Participation

I attended this symposium for the opportunity to (Check all that apply):

Network with other medical professionals

Continue my own professional development

Present my scientific/academic work

Other: (Please specify)

Participation Other: (Please specify)

Change in Practice

My practice was changed and improved in the following way(s) as a result of the content presented in the course? (Check all that apply)

Diagnostic approach

Therapeutic approach

Disease prevention or health education

System process improvement

No Change

Please check here and explain your choice:

Change in Practice Please check here and explain your choice:

Attend Again

I would attend another MCW Pancreatic Cancer Symposium

Yes

Maybe (Please specify)

Attend Again Maybe (Please specify)

Future Symposium

I think that future symposiums should include:

Commercial Bias

Was the symposium free of commercial bias?

Yes, the content presented was free of commercial bias.

No, there was commercial bias at the symposium. (Please explain)

Commercial Bias No, there was commercial bias at the symposium. (Please explain)

Comments

Please provide any additional comments you may have regarding the symposium:

Leave this field blank

Medical College of Wisconsin

Office of Continuing and Professional Education

2026 26110_15th Annual MCW Pancreatic Cancer Symposium Evaluation

You are here

2026 26110_15th Annual MCW Pancreatic Cancer Symposium Evaluation